Isotretinoin (accutane) and serious psychiatric adverse events [7] (multiple letters)

Journal of the American Academy of Dermatology

Volumn 48, Issue 2 SUPPL., 2003, Pages 306-308

  O'Connell, Kathryn A ^a   Wilkin, Jonathan K ^a   Pitts, Marilyn ^a   Ellis, Charles N ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN;

BRAIN FUNCTION; CLINICAL FEATURE; DEPRESSION; DRUG WITHDRAWAL; HUMAN; LETTER; MENTAL DISEASE; NEUROMUSCULAR DISEASE; NEUROPSYCHIATRY; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; RETINOL INTOXICATION; SUICIDAL BEHAVIOR;

EID: 0037329047     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.12     Document Type: Letter

References (8)

1. Center for Drug Evaluation and Research Drug Information: Accutane (isotretinoin) www.fda.gov/cder/drug/infopage/accutane/default.htm September 19, 2000 Advisory committee meeting transcripts Available at
2. CN Ellis KJ. Krach Uses and complications of isotretinoin therapy J Am Acad Dermatol 45 2001 S150 S157 (Suppl)
3. AK Silverman CN Ellis JJ. Voorhees Hypervitaminosis A syndrome: a paradigm of retinoid side effects J Am Acad Dermatol 16 1987 1027 1039
4. DG Jacobs NI Deutsch M. Brewer Suicide, depression, and isotretinoin: Is there a causal link? J Am Acad Dermatol 45 2001 S168 S175 (Suppl)
5. TM) 2000 Substance induced mood disorder
6. [package insert], Roche Laboratories Inc Accutane (isotretinoin) 2000-2002
7. W. Blaner Cellular metabolism and actions of 13-cis-retinoic acid J Am Acad Dermatol 45 2001 S129 S135
8. DR Bickers JH. Saurat Isotretinoin: a state of the art conference J Am Acad Dermatol 45 2001 S125 S128 (Suppl)